{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T07:21:44Z","timestamp":1781594504550,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The research was funded by the National Natural Science Foundation of China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1038\/s41433-024-03582-4","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T08:26:58Z","timestamp":1736584018000},"page":"548-555","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and safety of robotic Cyberknife radiotherapy in uveal melanoma: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"39","author":[{"given":"Kejie","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3582-1215","authenticated-orcid":false,"given":"Wenjuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,11]]},"reference":[{"key":"3582_CR1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102599","volume":"119","author":"M Wespiser","year":"2023","unstructured":"Wespiser M, Neidhardt E, Negrier S. Uveal melanoma: in the era of new treatments. Cancer Treat Rev. 2023;119:102599.","journal-title":"Cancer Treat Rev"},{"key":"3582_CR2","doi-asserted-by":"crossref","unstructured":"Fallico M, Raciti G, Longo A, Reibaldi M, Bonfiglio V, Russo A, et al. Current molecular and clinical insights into uveal melanoma (Review). Int J Oncol. 2021;58:10.","DOI":"10.3892\/ijo.2021.5190"},{"key":"3582_CR3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000512738","volume":"7","author":"P Manchegowda","year":"2021","unstructured":"Manchegowda P, Singh AD, Shields C, Kaliki S, Shah P, Gopal L, et al. Uveal melanoma in Asians: a review. Ocul Oncol Pathol. 2021;7:159\u201367.","journal-title":"Ocul Oncol Pathol"},{"key":"3582_CR4","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1167\/iovs.17-22376","volume":"58","author":"C Zhou","year":"2017","unstructured":"Zhou C, Wang Y, Jia R, Fan X. Conjunctival melanoma in chinese patients: local recurrence, metastasis, mortality, and comparisons with caucasian patients. Investig Ophthamol Vis Sci. 2017;58:5452\u20139.","journal-title":"Investig Ophthamol Vis Sci"},{"key":"3582_CR5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2021.11.007","volume":"166","author":"F Buonanno","year":"2022","unstructured":"Buonanno F, Conson M, de Almeida Ribeiro C, Oliviero C, Itta F, Liuzzi R, et al. Local tumor control and treatment related toxicity after plaque brachytherapy for uveal melanoma: a systematic review and a data pooled analysis. Radiother Oncol. 2022;166:15\u201325.","journal-title":"Radiother Oncol"},{"key":"3582_CR6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.31083\/j.fbl2702072","volume":"27","author":"S Ka\u0161telan","year":"2022","unstructured":"Ka\u0161telan S, Mrazovac Zimak D, Ivankovi\u0107 M, Markovi\u0107 I, Gverovi\u0107 Antunica A. Liver metastasis in uveal melanoma - treatment options and clinical outcome. Front Biosci. 2022;27:72.","journal-title":"Front Biosci"},{"key":"3582_CR7","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.ophtha.2008.04.025","volume":"115","author":"SE Coupland","year":"2008","unstructured":"Coupland SE, Campbell I, Damato B. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability. Ophthalmology. 2008;115:1778\u201385.","journal-title":"Ophthalmology"},{"key":"3582_CR8","doi-asserted-by":"crossref","unstructured":"Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol. 2006;124:1684\u201393.","DOI":"10.1001\/archopht.124.12.1684"},{"key":"3582_CR9","doi-asserted-by":"crossref","unstructured":"Kilby W, Dooley J, Kuduvalli G, Sayeh S, Maurer CR Jr. The CyberKnife\u00ae robotic radiosurgery system in 2010. Technol Cancer Res Treat. 2010;9:433\u201352.","DOI":"10.1177\/153303461000900502"},{"key":"3582_CR10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/ICU.0000000000000761","volume":"32","author":"DA Reichstein","year":"2021","unstructured":"Reichstein DA, Brock AL. Radiation therapy for uveal melanoma: a review of treatment methods available in 2021. Curr Opin Ophthalmol. 2021;32:183\u201390.","journal-title":"Curr Opin Ophthalmol"},{"key":"3582_CR11","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"3582_CR12","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1177\/09622802211047348","volume":"30","author":"S Cai","year":"2021","unstructured":"Cai S, Zhou J, Pan J. Estimating the sample mean and standard deviation from order statistics and sample size in meta-analysis. Stat Methods Med Res. 2021;30:2701\u201319.","journal-title":"Stat Methods Med Res"},{"key":"3582_CR13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"3582_CR14","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358.","journal-title":"Stat Med"},{"key":"3582_CR15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"key":"3582_CR16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/CMR.0000000000000199","volume":"26","author":"K Eibl-Lindner","year":"2016","unstructured":"Eibl-Lindner K, Fuerweger C, Nentwich M, Foerster P, Wowra B, Schaller U, et al. Robotic radiosurgery for the treatment of medium and large uveal melanoma. Melanoma Res. 2016;26:51\u201357.","journal-title":"Melanoma Res"},{"key":"3582_CR17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijrobp.2017.02.017","volume":"98","author":"G Yazici","year":"2017","unstructured":"Yazici G, Kiratli H, Ozyigit G, Sari SY, Cengiz M, Tarlan B, et al. Stereotactic radiosurgery and fractionated stereotactic radiation therapy for the treatment of uveal melanoma. Int J Radiat Oncol Biol Phys. 2017;98:152\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3582_CR18","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.oret.2020.03.031","volume":"4","author":"R Liegl","year":"2020","unstructured":"Liegl R, Schmelter V, Fuerweger C, Foerster MH, Muacevic A, Priglinger SG, et al. Robotic CyberKnife radiosurgery for ciliary body melanoma. Ophthalmol Retin. 2020;4:954\u20136.","journal-title":"Ophthalmol Retin"},{"key":"3582_CR19","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4274\/tjo.galenos.2019.78370","volume":"50","author":"GC Ozcan","year":"2020","unstructured":"Ozcan GC, Gunduz AK, Mirzayev I, Oysul K, Uysal H. Early results of stereotactic radiosurgery in uveal melanoma and risk factors for radiation retinopathy. Turkish J Ophthalmol. 2020;50:156\u201362.","journal-title":"Turkish J Ophthalmol"},{"key":"3582_CR20","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1080\/0284186X.2022.2135387","volume":"61","author":"C Baskan","year":"2022","unstructured":"Baskan C, Akkas EA, G\u00f6kce SE, Ozdogan S. Outcomes of fractionated CyberKnife radiosurgery in patients with choroidal malignant melanoma. Acta Oncol. 2022;61:1412\u20136.","journal-title":"Acta Oncol"},{"key":"3582_CR21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.radonc.2022.09.010","volume":"176","author":"G Yazici","year":"2022","unstructured":"Yazici G, Kiratli H, Ozyigit G, Sari SY, Elmali A, Yilmaz MT, et al. Every other day stereotactic radiation therapy for the treatment of uveal melanoma decreases toxicity. Radiother Oncol. 2022;176:39\u201345.","journal-title":"Radiother Oncol"},{"key":"3582_CR22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajo.2022.12.021","volume":"250","author":"R Liegl","year":"2023","unstructured":"Liegl R, Schmelter V, Fuerweger C, Ehret F, Priglinger S, Muacevic A, et al. Robotic CyberKnife radiosurgery for the treatment of choroidal and ciliary body. Am J Ophthalmol. 2023;250:177\u201385.","journal-title":"Am J Ophthalmol"},{"key":"3582_CR23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000527915","volume":"8","author":"V Schmelter","year":"2023","unstructured":"Schmelter V, Schneider F, Guenther SR, Fuerweger C, Muacevic A, Priglinger SG, et al. Local recurrence in choroidal melanomas following robotic assisted radiosurgery (CyberKnife). Ocul Oncol Pathol. 2023;8:221\u20139.","journal-title":"Ocul Oncol Pathol"},{"key":"3582_CR24","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1177\/030089160909500614","volume":"95","author":"SY Choi","year":"2009","unstructured":"Choi SY, Kim M-S, Yoo SY, Cho CK, Lhee CH, Lee DH, et al. Feasibility of image-guided robotic radiotherapy using three fractions for uveal melanoma. Tumor J. 2009;95:720\u20135.","journal-title":"Tumor J"},{"key":"3582_CR25","doi-asserted-by":"crossref","first-page":"e734","DOI":"10.1111\/aos.13418","volume":"95","author":"J Siedlecki","year":"2017","unstructured":"Siedlecki J, Reiterer V, Leicht S, Foerster P, Kortuem K, Schaller U, et al. Incidence of secondary glaucoma after treatment of uveal melanoma with robotic radiosurgery versus brachytherapy. Acta Ophthalmol. 2017;95:e734\u20139.","journal-title":"Acta Ophthalmol"},{"key":"3582_CR26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/OPTH.S89591","volume":"11","author":"BA Krantz","year":"2017","unstructured":"Krantz BA, Dave N, Komatsubara KM, Marr BP, Carvajal RD. Uveal melanoma: epidemiology, etiology, and treatment of primary disease. Clin Ophthalmol. 2017;11:279\u201389.","journal-title":"Clin Ophthalmol"},{"key":"3582_CR27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/bjophthalmol-2016-309034","volume":"101","author":"RD Carvajal","year":"2017","unstructured":"Carvajal RD, Schwartz GK, Tezel T, Marr B, Francis JH, Nathan PD. Metastatic disease from uveal melanoma: treatment options and future prospects. Br J Ophthalmol. 2017;101:38\u201344.","journal-title":"Br J Ophthalmol"},{"key":"3582_CR28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.12703\/r\/10-51","volume":"10","author":"AC Schefler","year":"2021","unstructured":"Schefler AC, Kim RS. Recent advancements in the management of retinoblastoma and uveal melanoma. Fac Rev. 2021;10:51.","journal-title":"Fac Rev"},{"key":"3582_CR29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.iio.0000195863.79181.4f","volume":"46","author":"IK Daftari","year":"2006","unstructured":"Daftari IK, Petti PL, Shrieve DC, Phillips TL. Newer radiation modalities for choroidal tumors. Int Ophthalmol Clin. 2006;46:69\u201379.","journal-title":"Int Ophthalmol Clin"},{"key":"3582_CR30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/153303460800700503","volume":"7","author":"A Muacevic","year":"2008","unstructured":"Muacevic A, Nentwich M, Wowra B, Staerk S, Kampik A, Schaller U. Development of a streamlined, non-invasive robotic radiosurgery method for treatment of uveal melanoma. Technol Cancer Res Treat. 2008;7:369\u201374.","journal-title":"Technol Cancer Res Treat"},{"key":"3582_CR31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/153303461000900502","volume":"9","author":"W Kilby","year":"2010","unstructured":"Kilby W, Dooley JR, Kuduvalli G, Sayeh S, Maurer CR Jr. The CyberKnife robotic radiosurgery system in 2010. Technol Cancer Res Treat. 2010;9:433\u201352.","journal-title":"Technol Cancer Res Treat"},{"key":"3582_CR32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/eye.2012.249","volume":"27","author":"C Groenewald","year":"2013","unstructured":"Groenewald C, Konstantinidis L, Damato B. Effects of radiotherapy on uveal melanomas and adjacent tissues. Eye. 2013;27:163\u201371.","journal-title":"Eye"},{"key":"3582_CR33","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00417-021-05472-x","volume":"260","author":"UY Guleser","year":"2022","unstructured":"Guleser UY, Sarici AM, Ucar D, Gonen B, Sengul Samanci N, \u00d6zg\u00fcro\u011flu M. Comparison of iodine-125 plaque brachytherapy and gamma knife stereotactic radiosurgery treatment outcomes for uveal melanoma patients. Graefes Arch Clin Exp Ophthalmol. 2022;260:1337\u201343.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3582_CR34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000328257","volume":"49","author":"L Desjardins","year":"2012","unstructured":"Desjardins L, Lumbroso-Le Rouic L, Levy-Gabriel C, Cassoux N, Dendale R, Mazal A, et al. Treatment of uveal melanoma by accelerated proton beam. Dev Ophthalmol. 2012;49:41\u201357.","journal-title":"Dev Ophthalmol"},{"key":"3582_CR35","doi-asserted-by":"crossref","unstructured":"Zemba M, Dumitrescu OM, Gheorghe AG, Radu M, Ionescu MA, Vatafu A, et al. Ocular complications of radiotherapy in uveal melanoma. Cancers. 2023;15:333.","DOI":"10.3390\/cancers15020333"},{"key":"3582_CR36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.oret.2022.08.026","volume":"7","author":"J Gollrad","year":"2023","unstructured":"Gollrad J, B\u00f6ker A, Vitzthum S, Besserer A, Heufelder J, Gauger U, et al. Proton therapy for 166 patients with Iris melanoma: side effects and oncologic outcomes. Ophthalmol Retina. 2023;7:266\u201374.","journal-title":"Ophthalmol Retina"},{"key":"3582_CR37","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1097\/IAE.0b013e318295f758","volume":"33","author":"BK Tran","year":"2013","unstructured":"Tran BK, Schalenbourg A, Bovey E, Zografos L, Wolfensberger TJ. Role of vitreoretinal surgery in maximizing treatment outcome following complications after proton therapy for uveal melanoma. Retina. 2013;33:1777\u201383.","journal-title":"Retina"},{"key":"3582_CR38","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/bjo.80.8.732","volume":"80","author":"P Summanen","year":"1996","unstructured":"Summanen P, Immonen I, Kivel\u00e4 T, Tommila P, Heikkonen J, Tarkkanen A. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma. Br J Ophthalmol. 1996;80:732\u20139.","journal-title":"Br J Ophthalmol"},{"key":"3582_CR39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.radonc.2021.01.030","volume":"157","author":"JGM van Beek","year":"2021","unstructured":"van Beek JGM, Ramdas WD, Angi M, van Rij CM, Naus NC, Kacperek A, et al. Local tumour control and radiation side effects for fractionated stereotactic photon beam radiotherapy compared to proton beam radiotherapy in uveal melanoma. Radiother Oncol. 2021;157:219\u201324.","journal-title":"Radiother Oncol"},{"key":"3582_CR40","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1136\/bjophthalmol-2013-303331","volume":"97","author":"G Beykin","year":"2013","unstructured":"Beykin G, Pe\u2019er J, Hemo Y, Frenkel S, Chowers I. Pars plana vitrectomy to repair retinal detachment following brachytherapy for uveal melanoma. Br J Ophthalmol. 2013;97:1534\u20137.","journal-title":"Br J Ophthalmol"},{"key":"3582_CR41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3928\/23258160-20140306-05","volume":"45","author":"RP Joye","year":"2014","unstructured":"Joye RP, Williams LB, Chan MD, Witkin AJ, Schirmer CM, Mignano JE, et al. Local control and results of Leksell Gamma Knife therapy for the treatment of uveal melanoma. Ophthalmic Surg Lasers Imaging Retin. 2014;45:125\u201331.","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"key":"3582_CR42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijrobp.2011.06.1957","volume":"83","author":"R Dunavoelgyi","year":"2012","unstructured":"Dunavoelgyi R, Dieckmann K, Gleiss A, Sacu S, Kircher K, Georgopoulos M, et al. Radiogenic side effects after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007. Int J Radiat Oncol Biol Phys. 2012;83:121\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3582_CR43","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ophtha.2020.06.030","volume":"128","author":"CA Espensen","year":"2021","unstructured":"Espensen CA, Kiilgaard JF, Appelt AL, Fog LS, Herault J, Maschi C, et al. Dose-response and normal tissue complication probabilities after proton therapy for choroidal melanoma. Ophthalmology. 2021;128:152\u201361.","journal-title":"Ophthalmology"},{"key":"3582_CR44","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/08820538.2021.2000623","volume":"37","author":"N Garc\u00eda-O\u2019Farrill","year":"2022","unstructured":"Garc\u00eda-O\u2019Farrill N, Pugazhendhi S, Karth PA, Hunter AA. Radiation retinopathy intricacies and advances in management. Semin Ophthalmol. 2022;37:417\u201335.","journal-title":"Semin Ophthalmol"},{"key":"3582_CR45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/APO.0000000000000271","volume":"9","author":"M Chang","year":"2020","unstructured":"Chang M, Dalvin LA, Mazloumi M, Martin A, Yaghy A, Yang X, et al. Prophylactic intravitreal bevacizumab after plaque radiotherapy for uveal melanoma: analysis of visual acuity, tumor response, and radiation complications in 1131 eyes based on patient age. Asia Pac J Ophthalmol. 2020;9:29\u201338.","journal-title":"Asia Pac J Ophthalmol"},{"key":"3582_CR46","volume":"2015","author":"IA Brito","year":"2015","unstructured":"Brito IA, Zacharias LC, Pimentel SL. Fellow eye macular edema improvement after intravitreal bevacizumab for radiation retinopathy. Case Rep Ophthalmol Med. 2015;2015:516921.","journal-title":"Case Rep Ophthalmol Med"},{"key":"3582_CR47","doi-asserted-by":"crossref","unstructured":"Montero JA, Yanez-Castro G, Sanchis-Merino ME, Ruiz-Moreno JM. Bevacizumab in vitreous haemorrhage secondary to radiation retinopathy. BMJ Case Rep. 2014;2014:bc2013203177.","DOI":"10.1136\/bcr-2013-203177"},{"key":"3582_CR48","first-page":"1877","volume":"7","author":"NV Shah","year":"2013","unstructured":"Shah NV, Houston SK, Markoe A, Murray TG. Combination therapy with triamcinolone acetonide and bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma. Clin Ophthalmol. 2013;7:1877\u201382.","journal-title":"Clin Ophthalmol"},{"key":"3582_CR49","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/a-0735-9865","volume":"237","author":"FS Filev","year":"2020","unstructured":"Filev FS, Mirshahi A. [Intravitreal therapy combining dexamethasone and bevacizumab in treating radiation retinopathy and opticopathy]. Klinische Monatsblatter fur Augenheilkd. 2020;237:319\u201322.","journal-title":"Klinische Monatsblatter fur Augenheilkd"},{"key":"3582_CR50","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000526548","volume":"8","author":"O Srivastava","year":"2023","unstructured":"Srivastava O, Weis E. Outcomes of second-line intravitreal Anti-VEGF switch therapy in radiation retinopathy secondary to uveal melanoma: moving from bevacizumab to aflibercept. Ocul Oncol Pathol. 2023;8:230\u20135.","journal-title":"Ocul Oncol Pathol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03582-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03582-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03582-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T10:13:44Z","timestamp":1738664024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03582-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,11]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["3582"],"URL":"https:\/\/doi.org\/10.1038\/s41433-024-03582-4","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,11]]},"assertion":[{"value":"3 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}